Featured Research

from universities, journals, and other organizations

Plant-Based Therapies Examined For Colon Cancer Prevention

Date:
September 24, 1997
Source:
The Rockefeller University
Summary:
Three therapies derived from plants will be tested at The Rockefeller University in New York City for their ability to prevent colorectal cancer, which afflicts some 150,000 Americans each year.  The compounds have the potential to be safer than cancer-thwarting nonsteroidal antiinflammatory drugs (NSAIDs), widely used aspirin-like drugs known to prevent colorectal cancer as well as reduce related deaths by half.

Three therapies derived from plants will be tested atThe Rockefeller University in New York City for theirability to prevent colorectal cancer, which afflictssome 150,000 Americans each year.  The compounds havethe potential to be safer than cancer-thwartingnonsteroidal antiinflammatory drugs (NSAIDs), widelyused aspirin-like drugs known to prevent colorectalcancer as well as reduce related deaths by half.

Eating diets rich in fruits and vegetables helpsreduce the risk of colorectal cancer as well as deathsfrom the disease, according to population-basedstudies.  However, the chemicals in these plantsresponsible for the anti-cancer effect are not wellknown.  "Certain plant-derived compounds calledphenolics act similarly to NSAIDs in hindering cancer,yet may lack their bad side effects such as irritatingthe stomach lining or damaging the liver or kidneys,"says Steven J. Shiff, M.D., assistant professor in theLaboratory of Human Behavior and Metabolism atRockefeller.  "If as effective or better than thedrugs, these plant therapies might be much bettertolerated for longer periods of time than NSAIDs."

In the study, Shiff and his colleagues will comparethree plant-derived compounds, curcumin, rutin andquercetin, to the NSAID sulindac.  The study willdetermine whether these naturally occuring chemicals,all potent antioxidants and antiinflammatories, canaffect cells in a similar manner as sulindac, whichprompts the cells to "turn on" a program of regulatedcell death called apoptosis.  NSAIDs, which includeibuprofen and naproxen, are among the most commonlyused therapies worldwide for relieving pain andinflammation in joints and muscles.

Curcumin, notes Shiff, has been used for centuries asan antiinflammatory agent.  The compound is thepigment that gives the yellow color to the seasoningcurry, mustard and turmeric, the powdered form of theroot of Curcuma longa Linn.  Curcumin is an approvedadditive for foods in the United States. Quercetin canbe naturally found in most fruits and vegetables, suchas cranberries and onions, as well as tea. Quercetin,when digested in the colon, breaks down into rutin.

Many colorectal cancers begin as noncancerous growths,called polyps, in the mucosal lining of the colon andrectum, the last part of the digestive tract.  Aninherited defective gene can cause some forms of thedisease, but not all.  The polyps develop because thenormal routine of cell division and apoptosis goesawry.  When apoptosis is disabled, tissues that relyon it no longer have a way to regulate their cellpopulations and cancer may ensue.

In the study, Shiff and fellow researchers willexamine the influence of administering differentamounts of either curcumin, rutin or quercetin on theamount of colorectal cells replaced and the speed ofthis process during the normal functions of theintestine.  The study includes looking for andmeasuring the size and kind of any intestinal polypsthat develop in the participants.

"Ideally, we would like to find the lowest, optimaldose of each of the three plant compounds that wouldsafely inhibit the development of colorectal cancer,"explains Shiff.

The study lasts for up to 10 weeks.  During the firsttwo weeks, participants eat a controlled diet so thatinitial information can be collected.  In thefollowing weeks, the investigators randomly assign theparticipants to continue on the initial diet alone ora diet supplemented with one of the plant phenoliccompounds or sulindac, the NSAID.  During this secondphase, participants stay for an additional four oreight weeks.

For the study, the research team will recruit men andwomen aged 18 years and older who have a history ofcolon polyps.  Participants may not smoke and shouldbe healthy.  People interested in enrolling asparticipants should call Dawn Stoddard, M.S.,F.N.P., at 1-212-327-7458 or write tostoddad@rockvax.rockefeller.edu.  Furtherinformation can be obtained by visiting RockefellerUniversity HospitalΉs website athttp://clinfo.rockefeller.edu.  All information iskept strictly confidential.

People accepted into the study must stay at TheRockefeller University Hospital, but may leave duringthe day to work after the initial week.  Allparticipants receive free medical examinations, allmeals and private lodging, and will be given a stipendfor their participation.  The National CancerInstitute, part of the federal National Institutes ofHealth (NIH), supports the Rockefeller study.

The Rockefeller University Hospital is the oldesthospital in the United States devoted solely toexperimental medicine.  Established in 1910, thehospital links laboratory investigations with bedsideobservations to provide a scientific basis for diseasedetection, prevention and treatment.  This specialhospital environment served as the model for theWarren G. Magnuson Clinical Center, opened at the NIHin 1953, and similar facilities supported by federalfunding at more than 75 medical schools in the UnitedStates.

Rockefeller University began in 1901 as theRockefeller Institute for Medical Research, the firstU.S. biomedical research center. Rockefeller facultymembers have made significant achievements, includingthe discovery that DNA is the carrier of geneticinformation and the launching of the scientific fieldof modern cell biology.  The university has ties to 19Nobel laureates, including the president, Torsten N.Wiesel, M.D., who received the prize in 1981.  Theuniversity recently created centers to foster researchof Alzheimer's Disease, of biochemistry and structuralbiology, of human genetics, of sensory neurosciencesand of the links between physics and biology.


Story Source:

The above story is based on materials provided by The Rockefeller University. Note: Materials may be edited for content and length.


Cite This Page:

The Rockefeller University. "Plant-Based Therapies Examined For Colon Cancer Prevention." ScienceDaily. ScienceDaily, 24 September 1997. <www.sciencedaily.com/releases/1997/09/970924033126.htm>.
The Rockefeller University. (1997, September 24). Plant-Based Therapies Examined For Colon Cancer Prevention. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1997/09/970924033126.htm
The Rockefeller University. "Plant-Based Therapies Examined For Colon Cancer Prevention." ScienceDaily. www.sciencedaily.com/releases/1997/09/970924033126.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:  

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile iPhone Android Web
      Follow Facebook Twitter Google+
      Subscribe RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins